Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
15.39
+0.61 (4.09%)
At close: Nov 11, 2026, 4:00 PM EST
15.22
-0.16 (-1.06%)
Pre-market: Nov 12, 2026, 4:57 AM EST
Iambic Therapeutics Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Iambic Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $27.25. The average 1-year stock price forecast is 77.12% higher than the current stock price, while the lowest is $22 (+43.00%) and the highest is $35 (+127.49%).
Price Target: $27.25 (+77.12%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Iambic Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Initiates $35 | Buy | Initiates | $35 | +127.49% | Nov 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 9, 2026 |
| Citi | Citi | Buy Initiates $22 | Buy | Initiates | $22 | +43.00% | Nov 9, 2026 |
Financial Forecast
Revenue This Year
30.71M
from 9.43M
Increased by 225.80%
Revenue Next Year
89.27M
from 30.71M
Increased by 190.68%
EPS This Year
-2.68
EPS Next Year
-3.06
from -2.68
EPS and Forward PE are based on non-GAAP adjusted numbers.